Pfizer/BioNTech Updated Covid-19 Vaccine Gets Canadian Approval
Express News | Pfizer/BioNTech's COVID-19 vaccine targeting the KP.2 variant has been approved in Canada.
Pfizer Canada And BioNTech Receive Health Canada Approval Of Omicron KP.2 Variant Adapted COVID-19 Vaccine
BioNTech Shares Poised for Further Upside Amid BNT327 Building Data, Morgan Stanley Says
European Equities Traded in the US as American Depositary Receipts Move Higher in Tuesday Trading
Exxon Mobil To $120? Here Are 10 Top Analyst Forecasts For Tuesday